E
Eric Lepage
Researcher at University of Paris
Publications - 132
Citations - 22157
Eric Lepage is an academic researcher from University of Paris. The author has contributed to research in topics: International Prognostic Index & Non-Hodgkin's lymphoma. The author has an hindex of 51, co-authored 132 publications receiving 21235 citations. Previous affiliations of Eric Lepage include Sorbonne.
Papers
More filters
Journal ArticleDOI
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
Bertrand Coiffier,Eric Lepage,Josette Brière,Raoul Herbrecht,Hervé Tilly,Reda Bouabdallah,Pierre Morel,Eric Van Den Neste,Gilles Salles,Philippe Gaulard,Felix Reyes,Pierre Lederlin,Christian Gisselbrecht +12 more
TL;DR: A randomized trial to compare CHOP chemotherapy plus rituximab with CHOP alone in elderly patients with diffuse large-B-cell lymphoma found the rate of complete response was significantly higher in the group that received CHOP plus r ituximabs than in thegroup that receivedCHOP alone.
Journal Article
A predictive model for aggressive non-Hodgkin's lymphoma
Margaret A. Shipp,D. P. Harrington,James R. Anderson,James Olen Armitage,Gianni Bonadonna,G. Brittinger,Fernando Cabanillas,George P. Canellos,Bertrand Coiffier,Joseph M. Connors,R. A. Cowan,D. Crowther,Steve Dahlberg,M. Engelhard,Richard I. Fisher,Christian Gisselbrecht,Sandra J. Horning,Eric Lepage,T. A. Lister,J. H. Meerwaldt,Emili Montserrat,Nis I. Nissen,M. M. Oken,Bruce A. Peterson,Carlo Tondini,W. A. Velasquez,B. Y. Yeap +26 more
TL;DR: The international index and the age-adjusted international index should be used in the design of future therapeutic trials in patients with aggressive non-Hodgkin's lymphoma and in the selection of appropriate therapeutic approaches for individual patients.
Journal ArticleDOI
Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte
P. Feugier,A. Van Hoof,Catherine Sebban,Philippe Solal-Celigny,R. Bouabdallah,Christophe Fermé,B. Christian,Eric Lepage,H. Tilly,F. Morschhauser,Philippe Gaulard,Gilles Salles,André Bosly,Christian Gisselbrecht,Felix Reyes,B. Coiffier +15 more
TL;DR: Using the combination of R-CHOP leads to significant improvement of the outcome of elderly patients with diffuse large B-cell lymphoma, with significant survival benefit maintained during a 5-year follow-up.
Journal ArticleDOI
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study.
Corinne Alberti,Christian Brun-Buisson,Hilmar Burchardi,Claudio Martin,Sergey Goodman,Antonio Artigas,Alberto Sicignano,Mark Palazzo,Rui Moreno,Ronan Boulme,Eric Lepage,Jean Roger Le Gall +11 more
TL;DR: The crude incidence of ICU infections remains high, although the rate varies between ICUs and patient subsets, illustrating the added burden of nosocomial infections in the use ofICU resources.
Journal ArticleDOI
Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte
Pauline Brice,Y. Bastion,Eric Lepage,Nicole Brousse,Corinne Haioun,Philippe Moreau,N Straetmans,H. Tilly,I Tabah,Philippe Solal-Celigny +9 more
TL;DR: Delayed treatment is feasible in patients with follicular lymphoma and a low tumor burden and the long-term toxicity of alkylating agents can be reduced.